Incision-triggered neuroimmune remodeling of nociceptor ion channels: from postoperative inflammation to pain chronification
- 1Department of Anesthesiology, The First Affiliated Hospital of Dalian Medical University
Abstract
Chronic postsurgical pain (CPSP) arises after a known tissue insult, yet no intervention reliably prevents its development. This Review examines whether incision-triggered inflammation remodels nociceptor voltage-gated ion channels in ways that sustain peripheral input and favor pain chronification. We integrate human genetic and clinical evidence, incision-specific perturbation studies, functional work in non-surgical models, and expression-level associations distinguishing mechanistic strength from directness to CPSP. We focus on NaV1.7, NaV1.8, NaV1.9, and CaV3.2 within a broader network that includes peripheral transducing channels whose gating, trafficking, and abundance can be altered by TNF-α, IL-1β, IL-6, chemokines, p38 MAPK, NF-κB, and gp130/JAK signaling. Direct incision evidence now includes antisense and pharmacologic studies linking TNF-α/p38/NF-κB signaling to NaV1.8 and NaV1.9 expression and acute hypersensitivity, as well as single-cell maps showing insult-specific macrophage and neutrophil programs and protective immune-derived signals. Evidence from rare channelopathies does not establish population-level CPSP susceptibility. However, no human study has demonstrated the complete sequence from a defined postoperative immune signal to altered channel function and persistent pain. Sex, age, and hormonal context are plausible modifiers, but the strongest mechanistic evidence remains model-dependent and preclinical. Selective NaV1.8 inhibition validates peripheral channel tractability for acute pain but not prevention of CPSP. We therefore propose a testable, evidence-calibrated framework in which pathogenic and resolving immune programs act across peripheral, ganglion, and spinal compartments, and we define the experiments, biomarkers, and target–time–population alignment needed to determine whether this framework can guide mechanism-based prevention.
Related
- A mouse neuroimmune circuit that regulates allergic inflammation in the esophagus
- The obesity–neuroinflammation–cancer axis: neuroimmune remodeling and therapeutic opportunities
- Mechanisms of neuroimmune crosstalk in vestibular disorders: Linking inflammation with neural circuit dysfunction (Review)
- A neuroimmune hypothesis linking chronic cervical inflammation to systemic symptoms: the role of the vagus–NTS axis
- Crystal Sensing and Neurogenic Inflammation in Gout: A Proposed Sensory Neuroimmune Framework for Flare Pain.
BibTeX
@article{song2026incisiontriggered,
title = {{Incision-triggered neuroimmune remodeling of nociceptor ion channels: from postoperative inflammation to pain chronification}},
author = {Xinye Song and Miao Feng and Jiachen Hao and Yong Luan},
journal = {Frontiers in Immunology},
year = {2026},
month = oct,
doi = {10.3389/fimmu.2026.1953337},
url = {https://www.frontiersin.org/articles/10.3389/fimmu.2026.1953337/full},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Incision-triggered neuroimmune remodeling of nociceptor ion channels: from postoperative inflammation to pain chronification
AU - Xinye Song
AU - Miao Feng
AU - Jiachen Hao
AU - Yong Luan
PY - 2026
DA - 2026/10/06
JO - Frontiers in Immunology
DO - 10.3389/fimmu.2026.1953337
UR - https://www.frontiersin.org/articles/10.3389/fimmu.2026.1953337/full
AB - Chronic postsurgical pain (CPSP) arises after a known tissue insult, yet no intervention reliably prevents its development. This Review examines whether incision-triggered inflammation remodels nociceptor voltage-gated ion channels in ways that sustain peripheral input and favor pain chronification. We integrate human genetic and clinical evidence, incision-specific perturbation studies, functional work in non-surgical models, and expression-level associations distinguishing mechanistic strength from directness to CPSP. We focus on NaV1.7, NaV1.8, NaV1.9, and CaV3.2 within a broader network that includes peripheral transducing channels whose gating, trafficking, and abundance can be altered by TNF-α, IL-1β, IL-6, chemokines, p38 MAPK, NF-κB, and gp130/JAK signaling. Direct incision evidence now includes antisense and pharmacologic studies linking TNF-α/p38/NF-κB signaling to NaV1.8 and NaV1.9 expression and acute hypersensitivity, as well as single-cell maps showing insult-specific macrophage and neutrophil programs and protective immune-derived signals. Evidence from rare channelopathies does not establish population-level CPSP susceptibility. However, no human study has demonstrated the complete sequence from a defined postoperative immune signal to altered channel function and persistent pain. Sex, age, and hormonal context are plausible modifiers, but the strongest mechanistic evidence remains model-dependent and preclinical. Selective NaV1.8 inhibition validates peripheral channel tractability for acute pain but not prevention of CPSP. We therefore propose a testable, evidence-calibrated framework in which pathogenic and resolving immune programs act across peripheral, ganglion, and spinal compartments, and we define the experiments, biomarkers, and target–time–population alignment needed to determine whether this framework can guide mechanism-based prevention.
SN - 1664-3224
ER -